Literature DB >> 35511032

Preserved Mucosal-Associated Invariant T Cells in the Cervical Mucosa of HIV-Infected Women with Dominant Expression of the TRAV1-2-TRAJ20 T Cell Receptor α-Chain.

Anna Gibbs1, Katie Healy2, Vilde Kaldhusdal1, Christopher Sundling1, Mathias Franzén-Boger1, Gabriella Edfeldt1, Marcus Buggert3, Julie Lajoie4,5, Keith R Fowke4,5,6,7, Joshua Kimani4,5,6, Douglas S Kwon8, Sonia Andersson9, Johan K Sandberg3, Kristina Broliden1, Haleh Davanian2, Margaret Sällberg Chen2, Annelie Tjernlund1.   

Abstract

BACKGROUND: Mucosa-associated invariant T (MAIT) cells are innate-like T cells with specialized antimicrobial functions. Circulating MAIT cells are depleted in chronic human immunodeficiency virus (HIV) infection, but studies examining this effect in peripheral tissues, such as the female genital tract, are lacking.
METHODS: Flow cytometry was used to investigate circulating MAIT cells in a cohort of HIV-seropositive (HIV+) and HIV-seronegative (HIV-) female sex workers (FSWs), and HIV- lower-risk women (LRW). In situ staining and quantitative polymerase chain reaction were performed to explore the phenotype of MAIT cells residing in paired cervicovaginal tissue. The cervicovaginal microbiome was assessed by means of 16S ribosomal RNA gene sequencing.
RESULTS: MAIT cells in the HIV+ FSW group were low in frequency in the circulation but preserved in the ectocervix. MAIT cell T-cell receptor gene segment usage differed between the HIV+ and HIV- FSW groups. The TRAV1-2-TRAJ20 transcript was the most highly expressed MAIT TRAJ gene detected in the ectocervix in the HIV+ FSW group. MAIT TRAVJ usage was not associated with specific genera in the vaginal microbiome.
CONCLUSIONS: MAIT cells residing in the ectocervix are numerically preserved irrespective of HIV infection status and displayed dominant expression of TRAV1-2-TRAJ20. These findings have implications for understanding the role of cervical MAIT cells in health and disease.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Entities:  

Keywords:  zzm321990 TRAV1-2–TRAJ20zzm321990 ; HIV; MAIT; TCR usage; cervical mucosa; microbiome

Mesh:

Substances:

Year:  2022        PMID: 35511032      PMCID: PMC9574661          DOI: 10.1093/infdis/jiac171

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   7.759


  41 in total

1.  Collection, isolation, and flow cytometric analysis of human endocervical samples.

Authors:  Jennifer A Juno; Genevieve Boily-Larouche; Julie Lajoie; Keith R Fowke
Journal:  J Vis Exp       Date:  2014-07-06       Impact factor: 1.355

2.  MAIT cells are imprinted by the microbiota in early life and promote tissue repair.

Authors:  Michael G Constantinides; Verena M Link; Samira Tamoutounour; Andrea C Wong; P Juliana Perez-Chaparro; Seong-Ji Han; Y Erin Chen; Kelin Li; Sepideh Farhat; Antonin Weckel; Siddharth R Krishnamurthy; Ivan Vujkovic-Cvijin; Jonathan L Linehan; Nicolas Bouladoux; E Dean Merrill; Sobhan Roy; Daniel J Cua; Erin J Adams; Avinash Bhandoola; Tiffany C Scharschmidt; Jeffrey Aubé; Michael A Fischbach; Yasmine Belkaid
Journal:  Science       Date:  2019-10-25       Impact factor: 47.728

Review 3.  MAIT Cells in Health and Disease.

Authors:  Nicholas M Provine; Paul Klenerman
Journal:  Annu Rev Immunol       Date:  2019-01-27       Impact factor: 28.527

4.  Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor.

Authors:  Rangsima Reantragoon; Lars Kjer-Nielsen; Onisha Patel; Zhenjun Chen; Patricia T Illing; Mugdha Bhati; Lyudmila Kostenko; Mandvi Bharadwaj; Bronwyn Meehan; Ted H Hansen; Dale I Godfrey; Jamie Rossjohn; James McCluskey
Journal:  J Exp Med       Date:  2012-03-12       Impact factor: 14.307

5.  An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals.

Authors:  F Tilloy; E Treiner; S H Park; C Garcia; F Lemonnier; H de la Salle; A Bendelac; M Bonneville; O Lantz
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

6.  Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma.

Authors:  Nicholas A Gherardin; Liyen Loh; Lorenztino Admojo; Alexander J Davenport; Kelden Richardson; Amy Rogers; Phillip K Darcy; Misty R Jenkins; H Miles Prince; Simon J Harrison; Hang Quach; David P Fairlie; Katherine Kedzierska; James McCluskey; Adam P Uldrich; Paul J Neeson; David S Ritchie; Dale I Godfrey
Journal:  Sci Rep       Date:  2018-03-07       Impact factor: 4.379

7.  Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients.

Authors:  Esther Merlini; Maddalena Cerrone; Bonnie van Wilgenburg; Leo Swadling; E Stefania Cannizzo; Antonella d'Arminio Monforte; Paul Klenerman; Giulia Marchetti
Journal:  Front Microbiol       Date:  2019-08-28       Impact factor: 6.064

Review 8.  MAIT cells, guardians of skin and mucosa?

Authors:  Isabelle Nel; Léo Bertrand; Amine Toubal; Agnès Lehuen
Journal:  Mucosal Immunol       Date:  2021-03-22       Impact factor: 7.313

9.  Expansion of donor-unrestricted MAIT cells with enhanced cytolytic function suitable for TCR redirection.

Authors:  Tiphaine Parrot; Katie Healy; Caroline Boulouis; Michał J Sobkowiak; Edwin Leeansyah; Soo Aleman; Antonio Bertoletti; Margaret Sällberg Chen; Johan K Sandberg
Journal:  JCI Insight       Date:  2021-03-08

10.  Human MAIT cells respond to and suppress HIV-1.

Authors:  Chansavath Phetsouphanh; Prabhjeet Phalora; Carl-Philipp Hackstein; John Thornhill; C Mee Ling Munier; Jodi Meyerowitz; Lyle Murray; Cloete VanVuuren; Dominique Goedhals; Linnea Drexhage; Rebecca Moore; Quentin J Sattentau; Jeffrey Yw Mak; David P Fairlie; Sarah Fidler; Anthony D Kelleher; John Frater; Paul Klenerman
Journal:  Elife       Date:  2021-12-24       Impact factor: 8.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.